Helmholtz Gemeinschaft


Human disease models in drug development

Item Type:Review
Title:Human disease models in drug development
Creators Name:Loewa, A. and Feng, J.J. and Hedtrich, S.
Abstract:Biomedical research is undergoing a paradigm shift towards approaches centred on human disease models owing to the notoriously high failure rates of the current drug development process. Major drivers for this transition are the limitations of animal models, which, despite remaining the gold standard in basic and preclinical research, suffer from interspecies differences and poor prediction of human physiological and pathological conditions. To bridge this translational gap, bioengineered human disease models with high clinical mimicry are being developed. In this Review, we discuss preclinical and clinical studies that benefited from these models, focusing on organoids, bioengineered tissue models and organs-on-chips. Furthermore, we provide a high-level design framework to facilitate clinical translation and accelerate drug development using bioengineered human disease models.
Keywords:Molecular Medicine, Translational Research
Source:Nature Reviews Bioengineering
Publisher:Springer Nature
Date:11 May 2023
Additional Information:Erratum in: Nat Rev Bioeng (13 Jun 2023)
Official Publication:https://doi.org/10.1038/s44222-023-00063-3
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library